Charles Rhyee Analyst PerformanceManaging Director at TD CowenCharles Rhyee is a stock analyst at TD Cowen focused in the medical sector, covering 19 publicly traded companies. Over the past year, Charles Rhyee has issued 6 stock ratings, including buy, hold, and sell recommendations. While full access to Charles Rhyee's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Charles Rhyee's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings43 Last 11 YearsBuy Recommendations79.49% 31 Buy RatingsCompanies Covered19 Unique Companies Ratings Distribution39RatingsDistribution of strong buy, buy, hold, and sell ratings by Charles Rhyee.RatingPercentageCount Strong Buy0.0%0 ratings Buy79.5%30 ratings Hold17.9%7 ratings Sell2.6%1 ratingsOut of 39 total stock ratings issued by Charles Rhyee at TD Cowen, the majority (79.5%) have been Buy recommendations, followed by 17.9% Hold and 2.6% Sell.Best & Worst CallsBest Call0000.0%NHAug 2019Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%TDOCJul 2020Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNYSE52.6% of companies on NYSE10 companiesNASDAQ47.4% of companies on NASDAQ9 companiesCharles Rhyee, an analyst at TD Cowen, currently covers 19 companies listed on NYSE and NASDAQ, with the majority traded on NYSE.Coverage FocusSector IconSectorPercentageMedical14 companies73.7%Miscellaneous2 companies10.5%Computer and Technology1 company5.3%Business Services1 company5.3%Retail/Wholesale1 company5.3%Charles Rhyee of TD Cowen specializes in stock coverage within the Medical sector, with additional focus on and Computer and Technology companies.Coverage IndustriesIndustryPercentageMEDICAL SERVICES6 companies31.6%MEDICAL INFO SYS2 companies10.5%DRUG STORES & PROPRIETARY STORES2 companies10.5%MED - OUTP/HM CRE1 company5.3%MED/DENTAL - SUPP1 company5.3%COMPUTER INTEGRATED SYSTEMS DESIGN1 company5.3%MED - HMO1 company5.3%DATA PROCESSING & PREPARATION1 company5.3%INTERNET SOFTWARE1 company5.3%HOLDING & OTHER INVESTMENT OFFICES1 company5.3%Miscellaneous1 company5.3%MANAGEMENT SERVICES1 company5.3% Charles Rhyee's Ratings History at TD Cowen Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export to Excel CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsVEEVVeeva Systems10/7/2025Upgrade$299.84$380.00Buy$0.0000.00% ROIOPCHOption Care Health10/2/2025Initiated Coverage$27.24$30.00Hold$0.0000.00% ROIMCKMcKesson9/24/2025Boost Price Target$760.40$864.00Buy$0.0000.00% ROIMEDPMedpace7/23/2025Reiterated Rating$477.73$366.00Sell$0.0000.00% ROIICLRIcon4/14/2025Downgrade$144.04$157.00Hold$0.0000.00% ROIMEDPMedpace4/14/2025Downgrade$297.72$328.00Hold$0.0000.00% ROI Stock Forecasts and Research Tools Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
